DNER and Miyoshi myopathy: In conclusion, extensive chromatin activation seems to be a unifying principle underlying multiple pathogenic mechanisms in MM, which suggests that epigenetic drugs such as, for example, BET inhibitors, may be appropriate as a backbone treatment for patients affected with this aggressive disease.